Neurophth finishes GMP facility for gene therapy products

The 8,000 sqm gene therapy-focused current good manufacturing practice (cGMP) production facility includes two drug substance production suites according to international standards

picture of

Breaking News

WuXi Biologics completes first GMP run at 24,000L line of MFG5 facility

With its total 60,000L capacity, MFG5 has now supported manufacture of late-phase and commercial projects across ...

Donaldson acquires bioprocessing equipment specialist for $46m

The US filtration specialist has acquired Italy-based Solaris Biotechnology

Neurophth finishes GMP facility for gene therapy products

The 8,000 sqm gene therapy-focused current good manufacturing practice (cGMP) production facility includes two drug ...

Overcoming the bioprocessing challenges of personalised medicines

The pharmaceutical industry is facing major challenges to both its traditional business model and the development of ...

PerkinElmer completes $5.25bn acquisition of antibody specialist

BioLegend has been acquired by PerkinElmer in the largest acquisition in the company's history

Mycenax builds first continuous bioprocessing lab in Taiwan

Cytiva has partnered with biopharma CDMO Mycenax Biotech to expand commercial manufacturing of its first biosimilar

Driving biotherapeutic development with advanced molecule characterisation

Evaluating and characterising complicated protein structures and the therapeutic activity of advanced biotherapeutic ...

Protagen Protein Services merges with GeneWerk

The move establishes a premier, protein and gene analytic testing service platform worldwide

Repligen plans Polymem acquisition to expand hollow fibre capabilities

The CDMO has made the acquisition to significantly expands hollow fibre membrane and module production capabilities for ...

Holding CAR-T cell therapies to a higher standard with ddPCR

Stringent quality control during manufacturing yields safer, more effective therapies, advise Mark White, Associate ...

Deciding on a chemistry, manufacturing and control strategy for biologic development

Khanh Ngo Courtney from Avomeen discusses what biopharmaceutical companies should keep in mind as they embark on their ...

Leveraging bioelectronic assays for cell-based therapy

Cell-based immunotherapies are revolutionising medicine; and, although they are relatively new, they are poised to ...

Thermo Fisher launches next-gen mass spectrometry solutions at summit

The new systems and software tools support scientists working across a wide range of applications, from proteomics ...

Avantor acquires RIM Bio to expand single-use business into China

Avantor has acquired a China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical ...